Tirzepatide denied for missing prior authorization by Cigna?

Cigna's specific coverage criteria for tirzepatide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Requires Prior Authorization for Tirzepatide

Prior authorization (PA) is Cigna's standard utilization-management gate for tirzepatide. Receiving this denial does not mean tirzepatide is inappropriate for you — it means Cigna requires documented clinical evidence before approving coverage. PA denials are among the most commonly overturned denials when the appeal is well-documented, because the standard is clinical sufficiency, not clinical judgment.

Cigna's PA criteria for tirzepatide will be specified in its published coverage/medical policy. The criteria reference the FDA-approved prescribing label and may include requirements around diagnosis, prior treatment history, clinical severity, and prescriber type. Obtain both documents before building your appeal.

## Your Federal Appeal Rights

Under ACA §2719 and ERISA §503, PA denials are fully subject to internal and external review. You typically have 180 days from the denial notice to file an internal appeal. External review is available for approximately 4 months after final internal denial. If your health may seriously deteriorate while waiting for standard review, request expedited review — Cigna must respond on a compressed timeline.

## Concrete Appeal Steps

1. Obtain the denial notice identifying which PA criteria were not satisfied. 2. Request Cigna's current PA criteria and coverage/medical policy for tirzepatide. 3. Review the FDA-approved prescribing label to understand the approved indication and what clinical parameters the label references. 4. Audit your chart for documentation of each PA criterion — identify what is present and what needs to be explicitly stated. 5. Have your prescriber submit a medical-necessity letter that addresses each criterion by name with specific chart citations. 6. File the internal appeal with the complete clinical package. 7. If denied internally, file for external review through your state insurance commissioner or the federal process.

## Documentation to Gather

• Confirmed diagnosis: chart notes with ICD-10 codes for the covered indication
• Objective clinical findings from your chart: relevant measurements and lab trends documented by your care team (values from your records, not thresholds cited here)
• Prior treatment history: a complete, dated list of prior agents, durations, and documented outcomes — this is often the most critical component of a PA appeal
• Clinical severity documentation: prescriber's assessment of disease burden, comorbidities, and risk of delaying treatment
• Prescriber medical-necessity letter: maps each Cigna PA criterion to a specific chart entry; cites the applicable professional society guideline (e.g., relevant ADA, AACE/ACE, or Obesity Medicine Association guidance) by organization name

## Criteria-Mapping Structure

Obtain Cigna's PA criteria list and construct a table: each criterion in the left column, the specific chart fact satisfying it in the middle column, and the source document with date in the right column. This format lets Cigna's medical reviewer confirm compliance at a glance. Incomplete or narrative-only appeals are the leading cause of avoidable PA appeal failures — structure is as important as substance.